1582 related articles for article (PubMed ID: 30224757)
1. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.
Coudray N; Ocampo PS; Sakellaropoulos T; Narula N; Snuderl M; Fenyö D; Moreira AL; Razavian N; Tsirigos A
Nat Med; 2018 Oct; 24(10):1559-1567. PubMed ID: 30224757
[TBL] [Abstract][Full Text] [Related]
2. Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Yu KH; Wang F; Berry GJ; Ré C; Altman RB; Snyder M; Kohane IS
J Am Med Inform Assoc; 2020 May; 27(5):757-769. PubMed ID: 32364237
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients.
Ding Y; Zhang L; Guo L; Wu C; Zhou J; Zhou Y; Ma J; Li X; Ji P; Wang M; Zhu W; Shi C; Li S; Wu W; Zhu W; Xiao D; Fu C; He Q; Sun R; Mao X; Lizaso A; Li B; Han-Zhang H; Zhang Z
Thorac Cancer; 2020 Jan; 11(1):103-112. PubMed ID: 31692283
[TBL] [Abstract][Full Text] [Related]
4. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
5. Classification of subtypes including LCNEC in lung cancer biopsy slides using convolutional neural network from scratch.
Yang JW; Song DH; An HJ; Seo SB
Sci Rep; 2022 Feb; 12(1):1830. PubMed ID: 35115593
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
[TBL] [Abstract][Full Text] [Related]
7. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
[TBL] [Abstract][Full Text] [Related]
8. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
van Zyl A; Schubert PT; Koegelenberg CFN
Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
[TBL] [Abstract][Full Text] [Related]
9. A Weak Supervision-based Framework for Automatic Lung Cancer Classification on Whole Slide Image.
Xu X; Hou R; Zhao W; Teng H; Sun J; Zhao J
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():1372-1375. PubMed ID: 33018244
[TBL] [Abstract][Full Text] [Related]
10. The effect of spatial resolution on deep learning classification of lung cancer histopathology.
Wiebe M; Haston C; Lamey M; Narayan A; Rajapakshe R
BJR Open; 2023; 5(1):20230008. PubMed ID: 37953867
[TBL] [Abstract][Full Text] [Related]
11. Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning.
Chen M; Zhang B; Topatana W; Cao J; Zhu H; Juengpanich S; Mao Q; Yu H; Cai X
NPJ Precis Oncol; 2020; 4():14. PubMed ID: 32550270
[TBL] [Abstract][Full Text] [Related]
12. High accuracy epidermal growth factor receptor mutation prediction via histopathological deep learning.
Zhao D; Zhao Y; He S; Liu Z; Li K; Zhang L; Zhang X; Wang S; Che N; Jin M
BMC Pulm Med; 2023 Jul; 23(1):244. PubMed ID: 37407963
[TBL] [Abstract][Full Text] [Related]
13. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
[TBL] [Abstract][Full Text] [Related]
14. A deep learning model for the classification of indeterminate lung carcinoma in biopsy whole slide images.
Kanavati F; Toyokawa G; Momosaki S; Takeoka H; Okamoto M; Yamazaki K; Takeo S; Iizuka O; Tsuneki M
Sci Rep; 2021 Apr; 11(1):8110. PubMed ID: 33854137
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
17. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
18. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
[TBL] [Abstract][Full Text] [Related]
20. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
